Skip Navigation


International Journal for Quality in Health Care Advance Access originally published online on August 12, 2005
International Journal for Quality in Health Care 2005 17(5):377-378; doi:10.1093/intqhc/mzi068
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/5/377    most recent
mzi068v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fernandez, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez, C. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal for Quality in Health Care vol. 17 no. 5 © The Author 2005. Published by Oxford University Press on behalf of International Society for Quality in Health Care; all rights reserved

Editorial

Publication of ethically suspect research: should it occur?

The first 10% of the full text of this article appears below.

In this issue of International Journal for Quality in Health Care, a prospective, observational study has been published that confirms frequent error in drug administration, a now well-recognized risk to patient safety [1–3]. As a peer-reviewer, I suggested rejection of this manuscript for publication on ethical grounds as it raises a series of ethical concerns including (i) lack of oversight by a Research Ethics Board (REB) or equivalent; (ii) lack of a written informed consent procedure; and (iii) the lack of intervention by the observers when potential harms to patients were identified. These concerns raise further issues. Which jurisdictional standards should apply in the assessment of research for publication? What are the consequences of rejecting . . . [Full Text of this Article]

Research ethics oversight

Lack of written informed consent

Lack of intervention by observers

What are the consequences of rejecting a manuscript? What are the potential benefits to publishing ethically suspect work?

Which jurisdictional standards should apply in the assessment of research for publication?

Conrad V. Fernandez

Division of Pediatric Hematology and Oncology, Department of Pediatrics, IWK Health Centre Halifax, Department of Bioethics, Dalhousie University, Nova Scotia, Canada


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Med. EthicsHome page
K A Finlay and C V Fernandez
Failure to report and provide commentary on research ethics board approval and informed consent in medical journals
J. Med. Ethics, October 1, 2008; 34(10): 761 - 764.
[Abstract] [Full Text] [PDF]